Digitoxin: International drug information (concise)

For abbreviations, symbols, and age group definitions show table

International Brand Names

International Brand Names by Country

For country code abbreviations (show table)

(AT) Austria: Digimerck;
(BE) Belgium: Digitaline nativelle;
(BR) Brazil: Digitaline | Digitoxina;
(CH) Switzerland: Digimerck | Digitoxin Streuli;
(DE) Germany: Digimed | Digimerck | Digimerck minor | Digimerck pico | Tardigal;
(GB) United Kingdom: Digitoxin Focus | Nativel digitaline;
(HU) Hungary: Carditoxin | Digimerck;
(JP) Japan: Digitoxin chugai | Digitoxin fujisawa | Digitoxin shionogi | Digitoxin taisho | Digitoxin yamanouchi;
(LT) Lithuania: Digimerck;
(LV) Latvia: Digimerck pico;
(NO) Norway: Digimerck;
(TH) Thailand: Digi;
(TR) Turkey: Digimerck

Index Terms

Crystodigin

Pharmacologic Category

Antiarrhythmic Agent, Class IV

Reported Use

Treatment of chronic heart failure due to systolic dysfunction, paroxysmal atrial fibrillation or atrial flutter, and tachyarrhythmia caused by atrial fibrillation or atrial flutter.

Dosage Range

Adults:

IV: 0.05 to 0.25 mg 1 to 3 times daily.

Oral: 0.05 to 0.1 mg 1 to 3 times daily.

Product Availability

Product available in various countries; not currently available in the US

Dosage Forms

Solution, Injection: 0.1 mg/mL, 0.25 mg/2.5 mL

Tablet, Oral: 0.05 mg, 0.07 mg, 0.1 mg

Topic 10449 Version 43.0

خرید پکیج

Digitoxin: International drug information (concise)